Press

Filter by tags
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute

Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute

  Award supports development of a pre-clinical cell-based assay platform to help scientists discover and test drug candidates for metastatic breast cancer
Xenogeneic Cross-Circulation for Physiological Support and Recovery of Ex Vivo Human Livers

Xenogeneic Cross-Circulation for Physiological Support and Recovery of Ex Vivo Human Livers

The scarcity of suitable donor livers highlights a continuing need for innovation to recover organs with reversible injuries in liver transplantation.
Immune Characterization of a Xenogeneic Human Lung Cross-Circulation Support System

Immune Characterization of a Xenogeneic Human Lung Cross-Circulation Support System

Improved approaches to expanding the pool of donor lungs suitable for transplantation are critically needed for the growing population with end-stage lung disease.
Technique for Xenogeneic Cross-Circulation to Support Human Donor Lungs Ex Vivo

Technique for Xenogeneic Cross-Circulation to Support Human Donor Lungs Ex Vivo

Xenogeneic cross-circulation (XC) is an experimental method for ex vivo organ support and recovery that could expand the pool of donor lungs suitable for transplantation. The objective of this study was to establish and validate...
Researchers Confirm Successful Rehabilitation and Recovery of Human Donor Lungs Previously Deemed Unfit for Transplant

Researchers Confirm Successful Rehabilitation and Recovery of Human Donor Lungs Previously Deemed Unfit for Transplant

Study demonstrates that a novel technique for regenerating donor lungs can increase the number of organs available for life-saving transplantation
Xenogeneic Cross-Circulation Supports Ex Vivo Human Livers for 24 Hours

Xenogeneic Cross-Circulation Supports Ex Vivo Human Livers for 24 Hours

Despite increasing use of machine perfusion as an organ preservation and rescue technique in liver transplantation, significant organ shortages and waitlist mortality highlight a continuing need for improved organ recovery methods. 
Xylyx Bio Collaboration Reveals New Insights into Tumor Drug Resistance

Xylyx Bio Collaboration Reveals New Insights into Tumor Drug Resistance

Researchers at the University of Illinois applied Xylyx Bio's IN SITE™ Metastasis Kit to evaluate a cancer therapeutic.
Commentary: The Ultimate Ex Vivo Lung Perfusion: Xenogeneic Cross-Circulation

Commentary: The Ultimate Ex Vivo Lung Perfusion: Xenogeneic Cross-Circulation

Xenogeneic cross-circulation is a promising method to recover marginal lungs. It may be more advantageous than EVLP but could introduce risks of zoonotic infections and sensitization to xenoantigens.
Xenogeneic Support for the Recovery of Human Donor Organs

Xenogeneic Support for the Recovery of Human Donor Organs

Advanced EVLP with xenogeneic support could complement machine perfusion modalities such as isolated EVLP to expand donor organ recovery and increase the number of lungs available for transplantation.